抄録
The impact of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma (RCC) is discussed herein with consideration of prolonged survival and quality of life. A nephrectomy can be indicated in a patient with good performance status and pulmonary metastases when adjuvant immunotherapy is an option. In contrast, in a patient with poor performance status and/or metastases including multiple organs, a nephrectomy is not indicated. To relieve symptoms, options other than nephrectomy should be considered.
本文言語 | English |
---|---|
ページ(範囲) | 1732-1737 |
ページ数 | 6 |
ジャーナル | Gan to kagaku ryoho. Cancer & chemotherapy |
巻 | 29 |
号 | 10 |
出版ステータス | Published - 2002 10月 |
ASJC Scopus subject areas
- 腫瘍学
- 癌研究